The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Aberrant expression of Class II major histocompatibility complex molecules by B cells and hyperexpression of Class I major histocompatibility complex molecules by insulin containing islets in Type 1 (insulin-dependent) diabetes mellitus
Open accessAbstract
SummaryTwenty-three patients with recent onset Type 1 (insulin-dependent) diabetes in whom residual insulin secreting B cells were present and 12 patients with disease of more prolonged duration (maximum 9 years), 8 of whom had residual B cells, were studied. Aberrant expression of Class II major histocompatibility complex molecules was demonstrated immunohistochemically on insulin secreting B cells in 21 out of 23 patients with recent onset disease and 6 of the patients with more prolonged disease. No such expression was seen on glucagon secreting A cells or somatostatin secreting D cells. Islets where there was marked hyperexpression of Class I major histocompatibility complex molecules on islet endocrine cells were seen in all cases in which residual B cells were present. Ninety-two per cent of insulin containing islets but only 1% of insulin deficient islets exhibited this phenomenon (p<0.001, Chi-squared test). There was evidence to suggest that both these abnormalities of major histocompatibility complex expression preceded insulitis within a given islet. They also appeared to be unique to Type 1 diabetes, being absent in pancreases of patients with Type 2 (non-insulin-dependent) diabetes, chronic pancreatitis, cystic fibrosis, graft-versus-host disease and Coxsackie B viral pancreatitis. The development of autoimmunity to B cells in Type 1 diabetes may be a “multistep” process in which abnormalities of major histocompatibility complex expression on islet endocrine cells are crucial events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathologic anatomy of the pancreas in juvenile diabetes mellitus
Gepts, W. (1965) · Diabetes · doi:10.2337/diab.14.10.619 · Cited by 1,345
Foulis, A. K., Liddle, C. N., Farquharson, M. A., Richmond, J. A., & Weir, R. S. (1986) · Diabetologia · doi:10.1007/bf00452061 · Cited by 469
Self-citationGepts, W., & De Mey, J. (1978) · Diabetes · doi:10.2337/diab.27.1.s251 · Cited by 209
Cited by
Regulation of Insulin Synthesis and Secretion and Pancreatic Beta-Cell Dysfunction in Diabetes
Fu, Z., R. Gilbert, E., & Liu, D. (2013) · Current Diabetes Reviews · doi:10.2174/157339913804143225 · Cited by 732
Analysis of islet inflammation in human type 1 diabetes
Willcox, A., Richardson, S. J., Bone, A. J., Foulis, A. K., & Morgan, N. G. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03860.x · Cited by 712
Self-citationSarvetnick, N., Liggitt, D., Pitts, S. L., Hansen, S. E., & Stewart, T. A. (1988) · Cell · doi:10.1016/0092-8674(88)90414-x · Cited by 464
IMMUNOREACTIVE α-INTERFERON IN INSULIN-SECRETING β CELLS IN TYPE 1 DIABETES MELLITUS
Foulis, A., Farquharson, M., & Meager, A. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91128-7 · Cited by 446
Self-citationRichardson, S. J., Willcox, A., Bone, A. J., Foulis, A. K., & Morgan, N. G. (2009) · Diabetologia · doi:10.1007/s00125-009-1276-0 · Cited by 384
Self-citationGut microbiota, probiotics and diabetes
Gomes, A. C., Bueno, A. A., de Souza, R. G. M., & Mota, J. F. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-60 · Cited by 363
Autoreactive T cells in type 1 diabetes
Pugliese, A. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94549 · Cited by 358
Itoh, N., Hanafusa, T., Miyazaki, A., Miyagawa, J., Yamagata, K., Yamamoto, K., Waguri, M., Imagawa, A., Tamura, S., & Inada, M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116835 · Cited by 346
Krogvold, L., Edwin, B., Buanes, T., Frisk, G., Skog, O., Anagandula, M., Korsgren, O., Undlien, D., Eike, M. C., Richardson, S. J., et al. (2015) · Diabetes · doi:10.2337/db14-1370 · Cited by 314
Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes
Richardson, S. J., Rodriguez-Calvo, T., Gerling, I. C., Mathews, C. E., Kaddis, J. S., Russell, M. A., Zeissler, M., Leete, P., Krogvold, L., Dahl-Jørgensen, K., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-4067-4 · Cited by 298
Nagaraju, K., Raben, N., Loeffler, L., Parker, T., Rochon, P. J., Lee, E., Danning, C., Wada, R., Thompson, C., Bahtiyar, G., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.9209 · Cited by 311
Allison, J., Campbell, I. L., Morahan, G., Mandel, T. E., Harrison, L. C., & Miller, J. F. A. P. (1988) · Nature · doi:10.1038/333529a0 · Cited by 265
How Does Type 1 Diabetes Develop?
Atkinson, M. A., Bluestone, J. A., Eisenbarth, G. S., Hebrok, M., Herold, K. C., Accili, D., Pietropaolo, M., Arvan, P. R., Von Herrath, M., Markel, D. S., et al. (2011) · Diabetes · doi:10.2337/db10-1797 · Cited by 232
Insulitis in human type 1 diabetes: The quest for an elusive lesion
In't Veld, P. (2011) · Islets · doi:10.4161/isl.3.4.15728 · Cited by 216
Recent advances in understanding type 1 diabetes
Christoffersson, G., Rodriguez-Calvo, T., & von Herrath, M. (2016) · F1000Research · doi:10.12688/f1000research.7356.1 · Cited by 32
Metadata
- Authors
- Foulis, A. K., Farquharson, M. A., & Hardman, R.
- Venue
- Diabetologia
- Published
- 1987-05
- Volume
- 30
- Issue
- 5
- Pages
- 333-343
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2003479771
- Cited by
- 248
- References
- 3
- FWCI
- 10.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.